Kubota Pharmaceutical Holdings Co., Ltd.

TSE:4596 Stock Report

Market Cap: JP¥2.8b

Kubota Pharmaceutical Holdings Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Ryo Kubota

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.1yrs
CEO ownership18.1%
Management average tenureno data
Board average tenure2yrs

Recent management updates

Recent updates

We're Hopeful That Kubota Pharmaceutical Holdings (TSE:4596) Will Use Its Cash Wisely

Mar 01
We're Hopeful That Kubota Pharmaceutical Holdings (TSE:4596) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Ryo Kubota's remuneration changed compared to Kubota Pharmaceutical Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-JP¥1b

Jun 30 2024n/an/a

-JP¥1b

Mar 31 2024n/an/a

-JP¥1b

Dec 31 2023n/an/a

-JP¥1b

Sep 30 2023n/an/a

-JP¥1b

Jun 30 2023n/an/a

-JP¥2b

Mar 31 2023n/an/a

-JP¥2b

Dec 31 2022n/an/a

-JP¥2b

Sep 30 2022n/an/a

-JP¥2b

Jun 30 2022n/an/a

-JP¥2b

Mar 31 2022n/an/a

-JP¥3b

Dec 31 2021n/an/a

-JP¥3b

Sep 30 2021n/an/a

-JP¥2b

Jun 30 2021n/an/a

-JP¥3b

Mar 31 2021n/an/a

-JP¥2b

Dec 31 2020n/an/a

-JP¥2b

Sep 30 2020n/an/a

-JP¥3b

Jun 30 2020n/an/a

-JP¥3b

Mar 31 2020n/an/a

-JP¥3b

Dec 31 2019n/an/a

-JP¥3b

Sep 30 2019n/an/a

-JP¥3b

Jun 30 2019n/an/a

-JP¥3b

Mar 31 2019n/an/a

-JP¥3b

Dec 31 2018JP¥85mJP¥62m

-JP¥3b

Compensation vs Market: Insufficient data to establish whether Ryo's total compensation is reasonable compared to companies of similar size in the JP market.

Compensation vs Earnings: Insufficient data to compare Ryo's compensation with company performance.

CEO

Ryo Kubota (58 yo)

9.1yrs

Tenure

JP¥84,604,000

Compensation

Dr. Ryo Kubota, M. D., Ph. D., Founded Acucela Inc. in 2002 and has been its Chairman since April 2005, Chief Executive Officer and President since December 2015. Dr. Kubota Founded Kubota Pharmaceutical H...

Board Members

NamePositionTenureCompensationOwnership
Ryo Kubota
Founder22.6yrsJP¥84.60m18.15%
¥ 502.3m
Iyo Ichikawa
Chief Business Officer & Director2yrsno datano data
Koichiro Yoshizaki
Independent Outside Director2yrsno datano data
Emiko Maki
Independent Outside Director2.8yrsno datano data
Tsutomu Horiuchi
Independent Outside Director2yrsno datano data

2.0yrs

Average Tenure

58yo

Average Age

Experienced Board: 4596's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 13:34
End of Day Share Price 2025/01/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kubota Pharmaceutical Holdings Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Yuko SakamakiCitigroup Inc